10-Q: Waters Corporation Reports Q1 2025 Results: Sales Up 4% Driven by Instrument Demand

Waters Corporation's Q1 2025 sales increased by 4%, driven by strong demand for LC, MS, and LC & MS instrument systems.

Summary

• Waters Corporation reported a 4% increase in net sales for the first quarter of 2025, reaching $661.7 million compared to $636.8 million in the first quarter of 2024.
• Foreign currency translation negatively impacted sales growth by 3%.
• Instrument system sales rose by 9%, while recurring revenues (chemistry consumables and services) increased by 1%.
• Operating income increased by 13% to $152 million, attributed to higher sales volume and the absence of restructuring and patent litigation expenses incurred in the previous year.
• Net income increased by 19% to $121.4 million, with diluted earnings per share at $2.03, up from $1.72 in the prior year.
• The company generated $260 million in net cash from operating activities.
• Capital expenditures for property, plant, equipment, and software capitalization totaled $26 million.
• The effective tax rate for the quarter was 15.1%, compared to 11.0% in the same period last year.
• The company has a $2.0 billion revolving credit facility, with $200 million outstanding as of March 29, 2025.
• The company's remaining share repurchase authorization is $1.0 billion.

Sentiment

Score: 7

Explanation: The report indicates positive financial performance with increased sales and income, but also acknowledges risks related to tariffs and currency fluctuations, resulting in a moderately positive sentiment.

Positives

• Net sales increased by 4% year-over-year.
• Instrument system sales showed strong growth, increasing by 9%.
• Operating income increased by 13% due to higher sales volume and reduced expenses.
• Net income and diluted earnings per share both increased significantly.
• The company generated strong cash flow from operating activities.
• The company has a Development and Expansion Incentive in Singapore that provides a concessionary income tax rate of 5% on certain types of income for the period April 1, 2021 through March 31, 2026.

Negatives

• Foreign currency translation negatively impacted sales growth by 3%.
• TA sales declined 1% in the first quarter of 2025 due to lower customer demand for TA products in most major regions except for Asia, where sales increased 15%.

Risks

• The company is subject to risks common to companies in the analytical instrument industry, including global economic and financial market conditions, fluctuations in foreign currency exchange rates, and technological innovations by competitors.
• Tariffs imposed by the U.S. government on imported goods could have a significant impact on the company's consolidated statement of operations and statement of cash flows.
• Economic conditions in China, trade tensions and tariffs between the U.S. and China and their impact on our business, increased competition from local and international competitors in China, the Chinese governments ongoing tightening of restrictions on procurement by government-funded customers and other regulatory and other challenges and uncertainties in the Chinese market.
• The company is exposed to the risk of exchange rate fluctuations.

Future Outlook

The company is continuing to evaluate and implement a series of actions and policies that are intended to offset a portion of the impact of the tariffs on the Company's financial position and results of operations.

Industry Context

The company operates in the analytical instrument industry, serving pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and government customers.

Comparison to Industry Standards

• Comparable companies in the analytical instrument industry include Agilent Technologies, Thermo Fisher Scientific, and Danaher Corporation.
• Waters' performance in Q1 2025 reflects a similar trend of growth in instrument sales observed across the industry, driven by demand in biopharma and industrial sectors.
• The company's focus on recurring revenues through consumables and services aligns with industry trends emphasizing stable and predictable income streams.

Legal Proceedings

• From time to time, the Company and its subsidiaries are involved in various litigation matters arising in the ordinary course of business.
• During the three months ended March 30, 2024, the Company recorded $10 million of patent litigation settlement provisions and related costs.

Stakeholder Impact

• Shareholders will likely react positively to the increased sales and earnings.
• Employees may benefit from the company's continued growth and profitability.
• Customers will continue to have access to the company's products and services.
• Suppliers will continue to have business with the company.

Next Steps

• The company anticipates spending approximately $130 million on the ERP implementation over the next three years.
• The U.S. government issued varying levels of tariffs on all imported goods into the U.S. The effective date of these tariffs has been delayed until July 2025 for all countries except China, as the U.S. seeks to negotiate these tariffs with each of the respective countries.

Key Dates

Keywords

Waters Corporation, financial results, quarterly report, net sales, operating income, instrument systems, chemistry consumables, service sales, earnings per share, cash flow, tax rate, share repurchase, debt, LC-MS, chromatography, mass spectrometry, thermal analysis